Baillie Gifford & Co. cut its stake in Waters Corporation (NYSE:WAT) by 0.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,947,133 shares of the medical instruments supplier’s stock after selling 13,840 shares during the period. Baillie Gifford & Co. owned 3.69% of Waters Corporation worth $529,068,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in WAT. Janus Henderson Group PLC raised its stake in shares of Waters Corporation by 20,670.6% in the second quarter. Janus Henderson Group PLC now owns 1,929,793 shares of the medical instruments supplier’s stock worth $354,773,000 after acquiring an additional 1,920,502 shares during the last quarter. Koch Industries Inc. raised its stake in shares of Waters Corporation by 36,932.0% in the second quarter. Koch Industries Inc. now owns 534,742 shares of the medical instruments supplier’s stock worth $532,000 after acquiring an additional 533,298 shares during the last quarter. Fundsmith LLP raised its stake in shares of Waters Corporation by 11.7% in the second quarter. Fundsmith LLP now owns 3,833,955 shares of the medical instruments supplier’s stock worth $704,834,000 after acquiring an additional 401,420 shares during the last quarter. Renaissance Technologies LLC raised its stake in shares of Waters Corporation by 214.5% in the second quarter. Renaissance Technologies LLC now owns 526,400 shares of the medical instruments supplier’s stock worth $96,773,000 after acquiring an additional 359,000 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its stake in shares of Waters Corporation by 1,244.6% in the second quarter. Arrowstreet Capital Limited Partnership now owns 228,590 shares of the medical instruments supplier’s stock worth $42,024,000 after acquiring an additional 211,590 shares during the last quarter. 91.08% of the stock is owned by institutional investors.
In other Waters Corporation news, Director Christopher A. Kuebler sold 3,500 shares of the firm’s stock in a transaction that occurred on Tuesday, August 8th. The shares were sold at an average price of $179.67, for a total transaction of $628,845.00. Following the completion of the transaction, the director now owns 17,849 shares in the company, valued at approximately $3,206,929.83. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Rohit Khanna sold 26,913 shares of the firm’s stock in a transaction that occurred on Friday, October 27th. The stock was sold at an average price of $197.93, for a total transaction of $5,326,890.09. Following the transaction, the senior vice president now owns 13,677 shares of the company’s stock, valued at approximately $2,707,088.61. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 48,813 shares of company stock valued at $9,374,087. Company insiders own 5.07% of the company’s stock.
WAT has been the subject of a number of research analyst reports. Zacks Investment Research raised shares of Waters Corporation from a “hold” rating to a “buy” rating and set a $202.00 target price for the company in a research note on Thursday, July 13th. BidaskClub downgraded shares of Waters Corporation from a “strong-buy” rating to a “buy” rating in a research note on Friday, July 28th. Barclays PLC boosted their target price on shares of Waters Corporation from $188.00 to $193.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 25th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $175.00 target price on shares of Waters Corporation in a research note on Thursday, July 27th. Finally, Deutsche Bank AG downgraded shares of Waters Corporation from a “buy” rating to a “hold” rating and boosted their target price for the stock from $183.00 to $194.00 in a research note on Monday, July 10th. Two analysts have rated the stock with a sell rating, nine have given a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Waters Corporation currently has an average rating of “Hold” and an average target price of $190.71.
Waters Corporation (NYSE WAT) traded up 0.39% during midday trading on Wednesday, hitting $196.81. 121,373 shares of the company were exchanged. The stock has a market capitalization of $15.71 billion, a PE ratio of 29.66 and a beta of 0.81. The firm’s 50-day moving average price is $185.85 and its 200-day moving average price is $180.47. Waters Corporation has a one year low of $133.35 and a one year high of $199.78.
Waters Corporation (NYSE:WAT) last released its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.03. Waters Corporation had a net margin of 24.34% and a return on equity of 23.61%. The firm had revenue of $565.58 million during the quarter, compared to analyst estimates of $555.25 million. During the same quarter last year, the business earned $1.57 EPS. The company’s revenue was up 7.4% compared to the same quarter last year. Equities research analysts anticipate that Waters Corporation will post $7.41 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “Waters Corporation (WAT) Shares Sold by Baillie Gifford & Co.” was posted by Community Financial News and is the property of of Community Financial News. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://www.com-unik.info/2017/11/01/waters-corporation-wat-shares-sold-by-baillie-gifford-co.html.
Waters Corporation Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
What are top analysts saying about Waters Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Waters Corporation and related companies.